6.405

0.00% -0.015

Fennec Pharmaceuticals Inc (FENC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$6.42

Offen:

$6.34

24-Stunden-Volumen:

95,537

Relative Volume:

0.61

Marktkapitalisierung:

$220.99M

Einnahmen:

$44.64M

Nettoeinkommen (Verlust:

$-10.10M

KGV:

-18.62

EPS:

-0.344

Netto-Cashflow:

$-14.45M

1W Leistung:

+11.26%

1M Leistung:

-16.62%

6M Leistung:

-34.09%

1J Leistung:

+22.28%

1-Tages-Spanne:

$6.34

$6.59

1-Wochen-Bereich:

$5.89

$6.59

52-Wochen-Spanne:

$4.68

$9.92

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Firmenname

Fennec Pharmaceuticals Inc

Sektor

Healthcare (1117)

Branche

Biotechnology (624)

Telefon

(919) 636-4530

Adresse

PO BOX 13628, RESEARCH TRIANGLE PARK, NC

Mitarbeiter

Twitter

@FennecPharma

Nächster Verdiensttermin

2026-03-24

Neueste SEC-Einreichungen

FENC's Discussions on Twitter

Compare FENC vs VRTX, REGN, ARGX, ALNY, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FENC Fennec Pharmaceuticals Inc	6.41	221.33M	44.64M	-10.10M	-14.45M	-0.344
VRTX Vertex Pharmaceuticals Inc	433.53	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.09	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	747.05	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	330.56	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	163.57	35.01B	606.42M	-1.28B	-997.58M	-6.403

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-12	Eingeleitet	B. Riley Securities	Buy
2026-01-09	Eingeleitet	Piper Sandler	Overweight
2022-11-22	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2022-09-07	Eingeleitet	CapitalOne	Overweight
2022-08-08	Fortgesetzt	Craig Hallum	Buy
2020-06-05	Eingeleitet	Cantor Fitzgerald	Overweight
2018-10-11	Eingeleitet	Goldman	Buy

Alle ansehen

Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten

Apr 05, 2026

Trend Recap: Can Fennec Pharmaceuticals Inc sustain earnings growth2026 Short Interest & Step-by-Step Swing Trade Plans - baoquankhu1.vn

Apr 05, 2026

(FENC) Risk Channels and Responsive Allocation - Stock Traders Daily

Apr 05, 2026

Apr 04, 2026

FENC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Adherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street Zen - MarketBeat

Apr 04, 2026

Apr 02, 2026

Adherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,946 Shares - MarketBeat

Apr 02, 2026

[Form 4] FENNEC PHARMACEUTICALS INC. Insider Trading Activity - Stock Titan

Apr 02, 2026

Fennec (FENC) CEO gets 200,000 options and new common shares - Stock Titan

Apr 02, 2026

FENNEC (FENC) director exercises 15,598 options and sells shares under 10b5-1 plan - Stock Titan

Apr 02, 2026

CMO at Fennec (NASDAQ: FENC) receives 120,000 stock options award - Stock Titan

Apr 02, 2026

Fennec (NASDAQ: FENC) CCO gets 120,000 options, 20,679 shares - Stock Titan

Apr 02, 2026

Public market insider net buying at Fennec Pharmaceuticals (FRX) - The Globe and Mail

Apr 02, 2026

FRX.CA Forecast, Price Target & Analyst Ratings | FENNEC PHARMACEUTICALS INC (TSX:FRX) - ChartMill

Apr 02, 2026

Apr 01, 2026

FENC (NASDAQ) insider sale notice: 10,946 shares via option exercise - Stock Titan

Apr 01, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Apr 01, 2026

HC Wainwright Has Bearish Forecast for FENC Q1 Earnings - MarketBeat

Apr 01, 2026

Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings - MarketBeat

Apr 01, 2026

Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 01, 2026

FENC Stock Price, Quote & Chart | FENNEC PHARMACEUTICALS INC (NASDAQ:FENC) - ChartMill

Apr 01, 2026

Mar 31, 2026

Aug Ideas: Does Fennec Pharmaceuticals Inc have a competitive edge2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn

Mar 31, 2026

Fennec Pharmaceuticals earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN

Mar 31, 2026

CEO Moves: Can Fennec Pharmaceuticals Inc expand its profit marginsWeekly Trade Analysis & Risk Controlled Daily Plans - baoquankhu1.vn

Mar 31, 2026

HC Wainwright Issues Negative Forecast for FENC Earnings - MarketBeat

Mar 31, 2026

24 new Fennec hires get options at $5.77 under Nasdaq rule - Stock Titan

Mar 31, 2026

Can Fennec Pharmaceuticals Inc stock double in the next yearStock Surge & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Income Plays: Does Fennec Pharmaceuticals Inc have a sustainable dividend2026 Fed Impact & High Return Stock Watch Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 28, 2026

Fennec Pharmaceuticals 2025 Annual Report: PEDMARK® Commercialization, Risks, and Intellectual Property Overview - Minichart

Mar 28, 2026

Adherex Technologies (NASDAQ:FENC) Cut to Strong Sell at Zacks Research - Defense World

Mar 28, 2026

Mar 27, 2026

Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds - TipRanks

Mar 27, 2026

Fennec Pharmaceuticals 2025 10-K: Revenue $44.6M, Net Loss $(9.7)M - TradingView

Mar 27, 2026

Fennec (NASDAQ: FENC) expands PEDMARK reach and delays generic entry - stocktitan.net

Mar 27, 2026

Adherex Technologies (NASDAQ:FENC) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat

Mar 27, 2026

Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat

Mar 27, 2026

Mar 26, 2026

Fennec (NASDAQ: FENC) CFO exercises 13,072 stock options in Form 4 - Stock Titan

Mar 26, 2026

Fennec (NASDAQ: FENC) Chief Strategy Officer exercises options, holds 145,300 shares - Stock Titan

Mar 26, 2026

Fennec Pharmaceuticals (FENC) Quarterly Loss Near Breakeven Challenges Bearish Profitability Narratives - Sahm

Mar 26, 2026

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 26, 2026

Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Can Afford To Invest In Growth - Yahoo Finance

Mar 26, 2026

Fennec Pharmaceuticals Hits Day Low of CAD 8.26 Amid Price Pressure - Markets Mojo

Mar 26, 2026

Mar 25, 2026

Fennec Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 25, 2026

Day Trade: Will Fennec Pharmaceuticals Inc benefit from AI trendsEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn

Mar 25, 2026

Adherex Technologies (FENC) to Release Earnings on Wednesday - MarketBeat

Mar 25, 2026

Fennec Pharmaceuticals Reports Record 2025 PEDMARK® Sales Growth and Financial Results, Highlights Pipeline and Global Expansion - Minichart

Mar 25, 2026

(FENC) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Mar 25, 2026

Mar 24, 2026

Fennec Pharmaceuticals Reports Record FY2025 Net Product Sales of $44.6M, Q4 Sales $13.8M - TradingView

Mar 24, 2026

Record PEDMARK growth but wider 2025 loss for Fennec (NASDAQ: FENC) - stocktitan.net

Mar 24, 2026